Home > > > > > Report Detail

Global Hemophilia Market Report: Insights, Trends and Forecast (2019-2023)

Publisher Name :
Date: 01-Jul-2019
No. of pages: 106
Inquire Before Buying

The global hemophilia market is estimated to reach US$12.98 billion in 2023, holding a CAGR of 6.21% in the duration spanning 2018-2023. The factors such as rise in diagnoses rate of hemophilia, rise in global healthcare expenditure and shifting focus to extended half-life (EHL) therapies are expected to drive the growth of the global hemophilia market. However, growth of the industry will be challenged by high price of treatment and reluctance to switch to new therapies. A few notable trends include shifting focus to Extended Half Life (EHL) therapies, development of novel hemophilia treatments and popularity of gene therapy.

The global hemophilia market comprises of two major segments: hemophilia A and hemophilia B. hemophilia A is four time prevalent than hemophilia B. The growing incidences of hemophilia A at vast rate has driven the increased demand for anti-hemophilia A or clotting factor VIII drugs. The pharmaceutical industry is flooded with drugs to be used in the treatment of type A, and thereby providing scope for the expansion of the global hemophilia market.

The fastest growing regional market in the hemophilia space is the U.S. due to High prevalence of hemophilia, coupled with rising inclination toward prophylaxis treatment. Rise in the population of hemophilia patients, is augmenting the need for more significant treatment methods. A lot of anti-hemophilia products are available in the market and several drugs are still in their late stage clinical process by large pharmaceutical firms. Furthermore, The U.S. and Europe are the highly established premium markets that contribute to considerable shares in the global hemophilia market.

Scope of the report:

- The report provides a comprehensive analysis of the global hemophilia market, segmented into hemophilia A and hemophilia B.

- The major regional markets (the U.S. and Europe) have been analyzed.

- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

- The competitive landscape of the market, along with the company profiles of leading players (Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited) are also presented in detail.

Key Target Audience:

- Hemophilia Drugs Manufacturers

- Raw Material Suppliers

- End Users (Hospital, Medical centers, Clinical Institutes)

- Healthcare Consulting Firms

- Investment Banks

- Government Bodies & Regulating Authorities

Global Hemophilia Market Report: Insights, Trends and Forecast (2019-2023)

Table of Contents

1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia
2. Global Market Analysis
2.1 Global Hemophilia Market by Value
2.2 Global Hemophilia Market Forecast by Value
2.3 Global Hemophilia Market by Treatment Regimen
2.4 Global Hemophilia Market by Type
2.4.1 Global Hemophilia A Market Forecast by Value
2.4.2 Global Hemophilia A Market by Severity
2.4.3 Global Hemophilia A Market by Treatment Type
2.4.4 Global Hemophilia A Market by Treatment Regimen
2.4.5 Global Hemophilia B Market Forecast by Value
2.4.6 Global Hemophilia B Market by Severity
2.4.7 Global Hemophilia B Market by Treatment Type
2.4.8 Global Hemophilia B Market by Treatment Regimen
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. Hemophilia Market by Value
3.1.2 The U.S. Hemophilia Market Forecast by Value
3.1.3 The U.S. Hemophilia Market by Type
3.1.4 The U.S. Hemophilia A Market Forecast by Value
3.1.5 The US Hemophilia A Market-Treated Patient Volume Forecast
3.1.6 The US Hemophilia A Market-Severe Patients on Prophylactic Therapy
3.1.7 The US Hemophilia A Market-Severe Patients on On-Demand Therapy
3.1.8 The US Hemophilia A Market-Mild to Moderate Patients on Prophylaxis Therapy
3.1.9 The US Hemophilia A Market-Mild to Moderate Patients on On-Demand Therapy
3.1.10 The US Hemophilia B Market Forecast by Value
3.1.11 The US Hemophilia B Market- Treated Patients Volume Forecast
3.1.12 The US Hemophilia B Market- Severe Patients on Prophylaxis Therapy
3.1.13 The US Hemophilia B Market- Severe Patients on On-Demand Therapy
3.1.14 The US Hemophilia B Market- Mild to Moderate Patients on Prophylaxis Therapy
3.1.15 The US Hemophilia B Market- Mild to Moderate Patients on On-Demand Therapy
3.2 Europe
3.2.1 Europe's Hemophilia Market- Patient Volume Forecast
3.2.2 Europe's Hemophilia A Market- Patient Volume Forecast
3.2.3 Europe's Hemophilia B Market- Patient Volume Forecast
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increased Focus on Prophylactic Treatment
4.1.2 Increasing Diagnosis Rate
4.1.3 Rise in Global Healthcare Expenditure
4.2 Key Trends & Development
4.2.1 Shifting Focus to Extended Half Life Therapies
4.2.2 Development of Novel Hemophilia Treatments
4.2.3 Popularity of Gene Therapy
4.3 Challenges
4.3.1 High Cost of Treatment
4.3.2 Reluctance to Switch to New Therapies
5. Competitive Landscape
5.1 The Global Market
5.1.1 Global Hemophilia A Market Share by Company
5.1.2 Global Hemophilia A Factor VIII Products Market Share by Company
5.1.3 Global Hemophilia A FVIII Gene Therapy Market Share Forecast
5.1.4 Global Hemophilia B Market Share by Company
5.1.5 Global Hemophilia B Factor IX Products Market Share Forecast
5.1.6 Global Hemophilia B Factor IX Gene Therapy Market Share Forecast
5.1.7 Key Players - Main Anti-Hemophilia Products
5.1.8 Key Players - Revenue Comparison
5.1.9 Key Players - Market Capital Comparison
5.2 The U.S. Market
The U.S. Hemophilia A Market Share by Company
5.3 Europe Market
Europe Hemophilia A Market Share by Company
6. Company Profiles
6.1 Pfizer Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bayer Group
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Sanofi S.A.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Takeda Pharmaceutical Company
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Novo Nordisk
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.6 CSL Limited
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies
List of Figures
Types of Hemophilia
Diagnosis of Hemophilia
Global Hemophilia Market by Value (2014-2018)
Global Hemophilia Market Forecast by Value (2019-2023)
Global Hemophilia Market by Treatment Regimen (2018)
Global Hemophilia Market by Type (2018)
Global Hemophilia A Market Forecast by Value (2018-2023)
Global Hemophilia A Market by Severity (2018)
Global Hemophilia A Market by Treatment Type (2018)
Global Hemophilia A Market by Treatment Regimen (2018/2023)
Global Hemophilia B Market Forecast by Value (2018-2023)
Global Hemophilia B Market by Severity (2018)
Global Hemophilia B Market by Treatment Type (2019)
Global Hemophilia B Market by Treatment Regimen (2018/2023)
The U.S. Hemophilia Market by Value (2014-2018)
The U.S. Hemophilia Market Forecast by Value (2019-2023)
The U.S. Hemophilia Market by Type (2018)
The U.S. Hemophilia A Market Forecast by Value (2018-2023)
The U.S. Hemophilia A Market-Treated Patient Volume Forecast (2018-2023)
The U.S. Hemophilia A Market-Severe Patients on Prophylactic Therapy (2018-2023)
The U.S. Hemophilia A Market-Severe Patients on On-Demand Therapy (2018-2023)
The U.S. Hemophilia A Market-Mild to Moderate Patients on Prophylaxis Therapy (2018-2023)
The U.S. Hemophilia A Market-Mild to Moderate Patients on On-Demand Therapy (2018-2023)
The U.S. Hemophilia B Market Forecast by Value (2018-2023)
The U.S. Hemophilia B Market- Treated Patients Volume Forecast (2018-2023)
The U.S. Hemophilia B Market- Severe Patients on Prophylaxis Therapy (2018-2023)
The U.S. Hemophilia B Market- Severe Patients on On-Demand Therapy (2018-2023)
The U.S. Hemophilia B Market- Mild to Moderate Patients on Prophylaxis Therapy (2018-2023)
The U.S. Hemophilia B Market- Mild to Moderate Patients on On-Demand Therapy (2018-2023)
Europe's Hemophilia Market- Patient Volume Forecast (2018-2023)
Europe's Hemophilia A Market- Patient Volume Forecast (2018-2023)
Europe's Hemophilia B Market- Patient Volume Forecast (2018-2023)
Global Market Share of Hemophilia A and B Patients on Prophylaxis (2018)
Global Identified Hemophilia Patients Volume (2011-2018)
Global Healthcare Expenditure (2014-2018)
Global Hemophilia A Market Share by Company (2017)
Global Hemophilia A Factor VIII Products Market Share by Company (2023/2030)
Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030)
Global Hemophilia B Market Share by Company (2017)
Global Hemophilia B Factor IX Products Market Share Forecast (2022/2030)
Global Hemophilia B Factor IX Gene Therapy Market Share Forecast (2030)
The US Hemophilia A Market Share by Company (2018)
Europe Hemophilia B Market Share by Company (2018)
Pfizer Inc. Revenue Share by Major Business Segment (2018)
Pfizer Inc. Revenue and Net Income (2014-2018)
Pfizer Inc. R&D Expenses (2016-2018)
Bayer Group Net Sales Share by Business Segments (2018)
Bayer Group Net Sales and Net Income (2014-2018)
Bayer Group R&D Expenses (2016-2018)
Sanofi S.A. Revenue Share by Segments (2018)
Sanofi S.A. Net Sales and Net Income (2014-2018)
Sanofi S.A. R&D Expenses (2016-2018)
Takeda Pharmaceutical Company Revenue Share by Region (2019)
Takeda Pharmaceutical Company Revenue and Net Income (2015-2019)
Takeda Pharmaceutical Company R&D Expenses (2017-2019)
Novo Nordisk Net Sales Share by Business Segments (2018)
Novo Nordisk Net Sales and Net Profit (2014-2018)
Novo Nordisk R&D Expenses (2016-2018)
CSL Limited Revenue Share by Segments (2018)
CSL Limited Sales Revenue and Net Profit (2014-2019)
CSL Limited R&D Expenses (2016-2018)
List of Tables
Signs & Symptoms of Hemophilia
Extended Half Life Products (2018)
Development of New Novel Hemophilia Treatments (2018)
Hemophilia Gene Therapy Candidates (2018)
Key Players - Main Anti-Hemophilia Products
Key Players - Revenue Comparison (2018)
Key Players - Market Capital Comparison (2019)
Major Products Developed by Pfizer Inc. (2018)
Major Products Developed by Bayer Group (2018)
Novo Nordisk Product Pipeline (2018)
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs